BioCentury | Sep 26, 2018
Company News

Management tracks: Merck clears path for Frazier to remain CEO

...CSO John Patton. Whitaker joins the company from respiratory disease company Vast Therapeutics Inc. (formerly Novoclem Therapeutics Inc....
Items per page:
1 - 1 of 1
BioCentury | Sep 26, 2018
Company News

Management tracks: Merck clears path for Frazier to remain CEO

...CSO John Patton. Whitaker joins the company from respiratory disease company Vast Therapeutics Inc. (formerly Novoclem Therapeutics Inc....
Items per page:
1 - 1 of 1